Lexeo Therapeutics (LXEO) Change in Account Payables (2022 - 2023)
Historic Change in Account Payables for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $394000.0.
- Lexeo Therapeutics' Change in Account Payables rose 13226.86% to $394000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$180000.0, marking a year-over-year change of. This contributed to the annual value of $2.4 million for FY2024, which is 142111.11% up from last year.
- Per Lexeo Therapeutics' latest filing, its Change in Account Payables stood at $394000.0 for Q4 2023, which was up 13226.86% from $290000.0 recorded in Q3 2023.
- Lexeo Therapeutics' Change in Account Payables' 5-year high stood at $1.0 million during Q1 2023, with a 5-year trough of -$1.9 million in Q2 2023.